Bamosiran
Bamosiran is an siRNA therapeutic candidate designed to selectively silence the β2-adrenergic receptor (ADRB2) gene, thereby lowering intraocular pressure. It is utilized in ophthalmic research, particularly for investigating novel mechanisms for glaucoma management in both in vitro and in vivo experimental models.
Product Specifications
CAS Number
1337968-84-9
Field of Research
Neuroscience, Pharmacology & Drug Discovery
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog